JP2005509630A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005509630A5 JP2005509630A5 JP2003537609A JP2003537609A JP2005509630A5 JP 2005509630 A5 JP2005509630 A5 JP 2005509630A5 JP 2003537609 A JP2003537609 A JP 2003537609A JP 2003537609 A JP2003537609 A JP 2003537609A JP 2005509630 A5 JP2005509630 A5 JP 2005509630A5
- Authority
- JP
- Japan
- Prior art keywords
- active layer
- pharmaceutical composition
- substance
- tablet according
- contained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 26
- 239000000126 substance Substances 0.000 claims 25
- 229960001879 ropinirole Drugs 0.000 claims 11
- UHSKFQJFRQCDBE-UHFFFAOYSA-N ropinirole Chemical compound CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2 UHSKFQJFRQCDBE-UHFFFAOYSA-N 0.000 claims 10
- 229920001477 hydrophilic polymer Polymers 0.000 claims 9
- 239000002671 adjuvant Substances 0.000 claims 8
- 230000004888 barrier function Effects 0.000 claims 7
- 239000002861 polymer material Substances 0.000 claims 7
- 239000000463 material Substances 0.000 claims 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 5
- 239000012530 fluid Substances 0.000 claims 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 5
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 5
- 239000013543 active substance Substances 0.000 claims 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 4
- 239000000499 gel Substances 0.000 claims 4
- 239000008206 lipophilic material Substances 0.000 claims 4
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 3
- 239000004359 castor oil Substances 0.000 claims 3
- 235000019438 castor oil Nutrition 0.000 claims 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 3
- 229940049654 glyceryl behenate Drugs 0.000 claims 3
- 229920001223 polyethylene glycol Polymers 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 229920001503 Glucan Polymers 0.000 claims 2
- -1 Polyoxyethylene, carboxyvinyl Polymers 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 235000013871 bee wax Nutrition 0.000 claims 2
- 239000012166 beeswax Substances 0.000 claims 2
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 claims 2
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 claims 2
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 claims 2
- 229920001577 copolymer Polymers 0.000 claims 2
- 230000003628 erosive effect Effects 0.000 claims 2
- 150000002191 fatty alcohols Chemical class 0.000 claims 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000008107 starch Substances 0.000 claims 2
- 235000019698 starch Nutrition 0.000 claims 2
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 claims 1
- SWNIFANHJGMBIM-UHFFFAOYSA-N 2,3-dihydroxypropyl hexadecanoate;octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(=O)OCC(O)CO SWNIFANHJGMBIM-UHFFFAOYSA-N 0.000 claims 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- 244000060011 Cocos nucifera Species 0.000 claims 1
- 235000013162 Cocos nucifera Nutrition 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 229920001353 Dextrin Polymers 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 229920000926 Galactomannan Polymers 0.000 claims 1
- 229920002148 Gellan gum Polymers 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- 229920000881 Modified starch Polymers 0.000 claims 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 244000299461 Theobroma cacao Species 0.000 claims 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 claims 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 239000000783 alginic acid Substances 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 229960001126 alginic acid Drugs 0.000 claims 1
- 150000004781 alginic acids Chemical class 0.000 claims 1
- 229940116224 behenate Drugs 0.000 claims 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 claims 1
- 235000001046 cacaotero Nutrition 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 229940105329 carboxymethylcellulose Drugs 0.000 claims 1
- 235000010418 carrageenan Nutrition 0.000 claims 1
- 239000000679 carrageenan Substances 0.000 claims 1
- 229920001525 carrageenan Polymers 0.000 claims 1
- 229940113118 carrageenan Drugs 0.000 claims 1
- 229960000541 cetyl alcohol Drugs 0.000 claims 1
- 229940074979 cetyl palmitate Drugs 0.000 claims 1
- 238000013270 controlled release Methods 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims 1
- 125000005456 glyceride group Chemical class 0.000 claims 1
- 229940100242 glycol stearate Drugs 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 235000019426 modified starch Nutrition 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 229920001983 poloxamer Polymers 0.000 claims 1
- 229960000502 poloxamer Drugs 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 150000004671 saturated fatty acids Chemical class 0.000 claims 1
- 235000003441 saturated fatty acids Nutrition 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 229920001285 xanthan gum Polymers 0.000 claims 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0125088.5A GB0125088D0 (en) | 2001-10-18 | 2001-10-18 | New use |
| PCT/EP2002/011568 WO2003035042A1 (en) | 2001-10-18 | 2002-10-16 | Use of a multi-layer controlled-release tablet comprising ropinirole for the manufacture of medicament for the treatment of fibromyalgia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005509630A JP2005509630A (ja) | 2005-04-14 |
| JP2005509630A5 true JP2005509630A5 (https=) | 2006-01-05 |
Family
ID=9924131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003537609A Withdrawn JP2005509630A (ja) | 2001-10-18 | 2002-10-16 | 繊維筋肉痛の治療のための医薬の製造における、ロピニロールを含んでなる多層制御放出錠剤の使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040247676A1 (https=) |
| EP (1) | EP1435921A1 (https=) |
| JP (1) | JP2005509630A (https=) |
| AR (1) | AR036838A1 (https=) |
| GB (1) | GB0125088D0 (https=) |
| WO (1) | WO2003035042A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PA8578501A1 (es) | 2002-07-25 | 2005-02-04 | Pharmacia Corp | Forma de dosificacion una vez al dia de pramipexol |
| ATE339192T1 (de) † | 2003-05-14 | 2006-10-15 | Eurand Pharmaceuticals Ltd | Kontrollierte medikamentfreigabe zusammensetzung mit in vivo mechanikstresswiderstand |
| GB0319874D0 (en) * | 2003-08-22 | 2003-09-24 | Glaxo Group Ltd | Novel formulation |
| US20060024368A1 (en) * | 2004-07-30 | 2006-02-02 | Reza Fassihi | Compressed composite delivery system for release-rate modulation of bioactives |
| CN101022788B (zh) | 2004-08-13 | 2010-11-10 | 贝林格尔·英格海姆国际有限公司 | 包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途 |
| DE102006043216A1 (de) * | 2006-06-02 | 2007-12-06 | Inoviscoat Gmbh | Verbundmaterial und Verfahren zum Herstellen eines derartigen Verbundmaterials |
| TW200815045A (en) * | 2006-06-29 | 2008-04-01 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of ropinirole and methods of use thereof |
| EP2175840A2 (en) * | 2007-08-14 | 2010-04-21 | Dr. Reddy's Laboratories, Ltd. | Pharmaceutical compositions comprising ropinirole |
| SI22849A (sl) * | 2008-08-01 | 2010-02-26 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Ropinirolni pripravek |
| US20110142905A1 (en) * | 2008-08-14 | 2011-06-16 | Bioneer A/S | Coated tablets with remaining degradation surface over the time |
| WO2010023693A2 (en) * | 2008-09-01 | 2010-03-04 | Lupin Limited | Novel controlled release compositions of ropinirole |
| EP2452677A1 (en) * | 2008-09-29 | 2012-05-16 | Wockhardt Limited | Extended release dosage form of ropinirole |
| WO2010044108A2 (en) | 2008-10-17 | 2010-04-22 | Rubicon Research Private Limited | Controlled release formulations of ropinirole |
| CN102470123B (zh) * | 2009-09-19 | 2013-08-28 | 浙江华海药业股份有限公司 | 含有多巴胺受体激动剂的药物组合物 |
| MX339408B (es) * | 2010-03-09 | 2016-05-24 | Alkermes Pharma Ireland Ltd | Composiciones farmaceuticas entericas resistentes al alcohol. |
| EP2830606A4 (en) * | 2012-03-30 | 2015-08-12 | Takeda Pharmaceuticals Usa Inc | FORMULATIONS OF COLCHICINE; MANUFACTURING PROCESSES ; AND ASSOCIATED METHODS OF USE |
| ITFI20130189A1 (it) * | 2013-08-05 | 2015-02-06 | Valpharma Internat S P A | Una composizione farmaceutica contenente ropinirolo hcl somministrabile per via orale e metodo di produzione. |
| MX377576B (es) * | 2014-01-22 | 2025-03-04 | Prilenia Neurotherapeutics Ltd | Formulaciones de pridopidina de liberación modificada. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR030557A1 (es) * | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
| IT1318470B1 (it) * | 2000-04-14 | 2003-08-25 | Jagotec Ag | Matrici polimeriche idrofile/lipofile, in grado di cedere sostanzefarmacologiamente attive a velocita' predeterminata. |
| US6277875B1 (en) * | 2000-07-17 | 2001-08-21 | Andrew J. Holman | Use of dopamine D2/D3 receptor agonists to treat fibromyalgia |
-
2001
- 2001-10-18 GB GBGB0125088.5A patent/GB0125088D0/en not_active Ceased
-
2002
- 2002-10-16 US US10/492,890 patent/US20040247676A1/en not_active Abandoned
- 2002-10-16 WO PCT/EP2002/011568 patent/WO2003035042A1/en not_active Ceased
- 2002-10-16 EP EP02779490A patent/EP1435921A1/en not_active Withdrawn
- 2002-10-16 AR ARP020103882A patent/AR036838A1/es not_active Application Discontinuation
- 2002-10-16 JP JP2003537609A patent/JP2005509630A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005509630A5 (https=) | ||
| ES2219709T3 (es) | Un comprimido farmaceutico caracterizado porque presenta un gran aumento de volumen cuando entra en contacto con fluidos biologicos. | |
| JP2003530423A5 (https=) | ||
| JP5670609B2 (ja) | 有効成分の制御送達のためのｏｒｏｓプッシュ−スティック | |
| JP3797388B2 (ja) | アルフゾシン塩酸塩の放出制御錠剤 | |
| CA2405508A1 (en) | Hydrophilic/lipophilic polymeric matrix dosage formulation | |
| JP5425058B2 (ja) | アルギン酸塩体を含む胃内滞留型システム | |
| Wang et al. | A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: design, in vitro and ‘in vivo’evaluation | |
| AU2005267738B2 (en) | A gastric retained dosage form of gabapentin | |
| WO2002003964A1 (fr) | Composition pharmaceutique orale a liberation controlee et a absorption prolongee | |
| JP2008503475A5 (https=) | ||
| WO2005079384A2 (en) | Expandable gastric retention device | |
| WO2014154029A1 (zh) | 复合骨架材料及其药物组合物 | |
| IL102777A (en) | Pharmaceutical combination formulation | |
| CA2806752A1 (en) | Oral dosage form of pregabalin | |
| EP0948320A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF THE HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN | |
| Mondal | The role of matrix tablet in drug delivery system | |
| JP2005509630A (ja) | 繊維筋肉痛の治療のための医薬の製造における、ロピニロールを含んでなる多層制御放出錠剤の使用 | |
| PL215262B1 (pl) | System terapeutyczny w postaci blony | |
| Sathish et al. | Floating drug delivery systems for prolonging gastric residence time: a review | |
| WO2019115501A1 (en) | Oral gastroretentive sustained-release pharmaceutical formulation | |
| Zope Janhavi et al. | A Comprehensive Review on Gastro-Retentive Floating Drug Delivery Systems | |
| Katakam et al. | Floating drug delivery systems: a review | |
| RU2006140649A (ru) | Содержащий эстриол пленочный лекарственный препарат для перорального приема | |
| Sinha et al. | Gastroretentive drug delivery approaches for oral bioavailability improvement |